Farther Finance Advisors »

Diamedica Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $34k 4.2k 7.96

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Microsoft Corp Stock (MSFT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Value Etf Etf (VTV)

View all positions for Farther Finance Advisors

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
First Manhattan
State Street Corporation
Bleichroeder
Northern Trust
LPL Financial
Advisor Group Holdings
CI Private Wealth
Corient IA
Members Wealth

View all funds holding Diamedica Therapeutics